Erratum: MCM2 and MCM5 as prognostic markers in colon cancer: A worthwhile approach (Digestive Diseases and Sciences (2009) 54 (698) DOI: 10.1007/s10620-008-0416-6);MCM2 and MCM5 as prognostic markers in colon cancer: A worthwhile approach

Digestive Diseases and Sciences

Volumn 54, Issue 2, 2009, Pages 197-198

  Burger, Maximilian ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; DNA; KI 67 ANTIGEN; MICRORNA; MINICHROMOSOME MAINTENANCE PROTEIN 2; MINICHROMOSOME MAINTENANCE PROTEIN 5; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P53; TUMOR MARKER;

CANCER LOCALIZATION; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN; CLINICAL FEATURE; COLORECTAL CANCER; DNA REPLICATION; EDITORIAL; EUKARYOTIC CELL; GLUCOSE HOMEOSTASIS; HEREDITY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 59449101434     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0521-6     Document Type: Erratum

References (10)

1. S Theocharis C Giaginis A Parasi A Margeli J Kakisis E Agapitos G Kouraklis 2007 Expression of peroxisome proliferator-activated receptor-gamma in colon cancer: correlation with histopathological parameters, cell cycle-related molecules, and patients' survival Dig Dis Sci 52 9 2305 2311 Sep
2. D Maiorano M Lutzmann M Mechali 2006 MCM proteins and DNA replication Curr Opin Cell Biol 18 130
3. EC Obermann P Went A Zimpfer A Tzankov PJ Wild R Stoehr 2005 Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis BMC Cancer 20 5 162
4. KE Tachibana MA Gonzalez N Coleman 2005 Cell-cycle-dependent regulation of DNA replication and its relevance to cancer pathology J Pathol 205 123
5. MG Mutch 2007 Molecular profiling and risk stratification of adenocarcinoma of the colon J Surg Oncol 96 8 693 703
6. MG Barrera B Trejo P Luna-Péerez F López-Barrera GM Escalera C Clapp 2006 Opposite association of serum prolactin and survival in patients with colon and rectal carcinomas: influence of preoperative radiotherapy Dig Dis Sci 51 1 54 62 Jan
7. AJ Schetter SY Leung JJ Sohn KA Zanetti ED Bowman N Yanaihara ST Yuen TL Chan DL Kwong GK Au CG Liu GA Calin CM Croce CC Harris 2008 MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma JAMA 299 4 425 436 Jan 30
8. GT MacLennan Z Kirkali L Cheng 2007 Histologic grading of noninvasive papillary urothelial neoplasms Eur Urol 51 4 889 897 Apr
9. Burger M, van der Aa MN, van Oers JM, Brinkmann A, van der Kwast TH, Steyerberg EC, Stoehr R, Kirkels WJ, Denzinger S, Wild PJ, Wieland WF, Hofstaedter F, Hartmann A, Zwarthoff EC (2007) Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 Grading and by FGFR3 mutation status: a prospective study. Eur Urol Dec 26; [Epub ahead of print]
10. Montironi R, Lopez-Beltran A, Cheng L (2007) Editorial comment on: prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study. Eur Urol Dec 26; [Epub ahead of print]